Health Catalyst Ownership
| HCAT Stock | USD 4.33 0.18 3.99% |
Shares in Circulation | First Issued 2018-03-31 | Previous Quarter 60.4 M | Current Value 62.4 M | Avarage Shares Outstanding 45.3 M | Quarterly Volatility 12.1 M |
Health |
Health Stock Ownership Analysis
About 77.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.87. Some equities with similar Price to Book (P/B) outperform the market in the long run. Health Catalyst recorded a loss per share of 1.17. The entity had not issued any dividends in recent years. Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah. Health Catalyst operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 1200 people. To learn more about Health Catalyst call Daniel Burton at (801) 708-6800 or check out https://www.healthcatalyst.com.Health Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Health Catalyst is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Health Catalyst backward and forwards among themselves. Health Catalyst's institutional investor refers to the entity that pools money to purchase Health Catalyst's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2024-12-31 | 1.4 M | Bank Of New York Mellon Corp | 2024-12-31 | 1.4 M | Jpmorgan Chase & Co | 2024-12-31 | 1.2 M | State Street Corp | 2024-12-31 | 1.2 M | Goldman Sachs Group Inc | 2024-12-31 | 886.7 K | Portolan Capital Management, Llc | 2024-12-31 | 749 K | American Century Companies Inc | 2024-12-31 | 710.5 K | Nuveen Asset Management, Llc | 2024-12-31 | 593.6 K | Northern Trust Corp | 2024-12-31 | 526.6 K | Blackrock Inc | 2024-12-31 | 5.6 M | First Light Asset Management, Llc | 2024-12-31 | 5.2 M |
Health Catalyst Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Health Catalyst insiders, such as employees or executives, is commonly permitted as long as it does not rely on Health Catalyst's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Health Catalyst insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Health Catalyst Outstanding Bonds
Health Catalyst issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Health Catalyst uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Health bonds can be classified according to their maturity, which is the date when Health Catalyst has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US42226AAA51 Corp BondUS42226AAA51 | View | |
| HEALTHCARE TRUST OF Corp BondUS42225UAH77 | View | |
| US42225UAG94 Corp BondUS42225UAG94 | View | |
| HR 3625 15 JAN 28 Corp BondUS42225UAK07 | View | |
| HR 205 15 MAR 31 Corp BondUS42225UAM62 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| HR 24 15 MAR 30 Corp BondUS42225UAL89 | View | |
| HEALTHCARE TR AMER Corp BondUS42225UAD63 | View |
Health Catalyst Corporate Filings
F4 | 10th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 26th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 7th of February 2025 Other Reports | ViewVerify | |
| 6th of February 2025 Other Reports | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Health Stock Analysis
When running Health Catalyst's price analysis, check to measure Health Catalyst's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Catalyst is operating at the current time. Most of Health Catalyst's value examination focuses on studying past and present price action to predict the probability of Health Catalyst's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Catalyst's price. Additionally, you may evaluate how the addition of Health Catalyst to your portfolios can decrease your overall portfolio volatility.